Virtual Medicinal Product (VMP) - Lamivudine 300mg / Tenofovir disoproxil 245mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Lamivudine 300mg / Tenofovir disoproxil 245mg tablets | Start Date 21-10-2019 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
- J05AR12
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 37845311000001102 | 21-10-2019 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Lamivudine | Based on Ingredient Substance | 300 mg | ||
| Tenofovir disoproxil | Based on Ingredient Substance | 245 mg |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Name
Tenofovir disoproxil
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
245
Strength and UOM (Dmr)
Parent Products
-
VTMLamivudine + Tenofovir disoproxil
-
VMP(Current) Lamivudine 300mg / Tenofovir disopro...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet | ||
| 90 tablet |